What Are the Downsides of Reishi? Side Effects, Risks, and Limitations Explained

Reishi (Ganoderma lucidum) is widely studied for immune modulation and stress adaptation, but it carries real limitations and side effects that are often underreported. Understanding these downsides is essential before adding reishi to your routine.

Common Side Effects

The most frequently reported side effects of reishi mushroom are gastrointestinal in nature. Users commonly experience nausea, stomach upset, loose stools, and bloating, particularly when starting supplementation or taking high doses. These effects are thought to stem from the dense polysaccharide and triterpene content, which can be irritating to sensitive digestive systems. Dry mouth and skin rash have also been noted in some clinical observations, though these tend to be mild and resolve with discontinuation.

Bleeding Risk and Drug Interactions

One of the more clinically significant downsides is reishi's potential to inhibit platelet aggregation. The triterpenoids found in reishi — particularly ganoderic acids — have demonstrated antiplatelet activity in laboratory and some human studies. This means reishi may potentiate the effects of anticoagulant and antiplatelet medications such as warfarin, aspirin, and clopidogrel, increasing the risk of bruising or bleeding. Anyone scheduled for surgery is generally advised to discontinue reishi at least two weeks beforehand. People on blood-thinning medications should consult a clinician before use.

Liver Toxicity Concerns

Although rare, hepatotoxicity (liver injury) has been documented in case reports linked to reishi supplementation. These cases are primarily associated with powdered whole-mushroom products rather than hot-water extracts, and in several instances involved prolonged use at high doses. Ganoderma lucidum (red reishi) and Ganoderma sinense (black reishi) are both implicated in the broader category of products under scrutiny. The mechanism is not fully established but may involve contaminants, adulterants, or idiosyncratic reactions. Baseline and periodic liver enzyme monitoring is reasonable for long-term users, especially those with pre-existing hepatic conditions.

Immunomodulatory Cautions

Reishi is frequently marketed for immune support, but its immunomodulatory properties are a double-edged consideration. For people with autoimmune conditions — such as lupus, rheumatoid arthritis, or multiple sclerosis — stimulating immune activity could theoretically exacerbate symptoms. Reishi mushroom acts on multiple immune pathways, including macrophage activation and natural killer cell enhancement, which is beneficial in healthy individuals but potentially problematic when immune regulation is already dysregulated. Similarly, individuals taking immunosuppressant drugs (e.g., post-organ transplant) should avoid reishi without medical supervision, as it may reduce the effectiveness of these medications.

Evidence Quality and Realistic Expectations

A frequently overlooked downside is the state of the evidence itself. Much of the human research on reishi involves small sample sizes, short durations, and varying extract standardization. Many studies use proprietary preparations that are difficult to replicate or compare. Claims around sleep, anxiety, and longevity — while biologically plausible — remain insufficiently supported by large-scale randomized controlled trials. Consumers should be cautious of products making strong therapeutic claims, particularly those using non-standardized wild reishi or unverified supply chains where contamination with heavy metals or pesticides is a genuine risk.

Who Should Avoid Reishi

• Pregnant or breastfeeding individuals: Insufficient safety data; avoid unless directed by a physician.
• People with bleeding disorders: Antiplatelet effects elevate risk.
• Those on immunosuppressants or anticoagulants: Significant interaction potential.
• Individuals with active liver disease: Case reports warrant caution.
• Children: No established pediatric safety data.

Practical Guidance on Dose and Form

Most adverse effects are dose-dependent. Typical study doses range from 1.5–9 g/day of dried mushroom or 1–1.5 g/day of concentrated extract. Starting low (around 500 mg of extract) and increasing gradually allows tolerance assessment. Hot-water extracts are generally considered lower risk for liver-related concerns than raw powders. Cycling use — for example, five days on, two days off — is a common pragmatic approach, though clinical evidence for this protocol is limited.

---

Related topics:

• Immune Support
• Stress
• Inflammation